6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Akari Therapeutics Plc
Filed: March 5, 2013
Period of Report: March 5, 2013
Accession Number: 0001144204-13-012925

View Document ↗ View on SEC.gov ↗